What is Adaptive Biotechnologies's total revenue?

Adaptive Biotechnologies (ADPT) reported total revenue of $70.87M in Q1 2026.

How has Adaptive Biotechnologies's total revenue changed year-over-year?

Adaptive Biotechnologies's total revenue increased by 35.1% year-over-year, from $52.44M to $70.87M.

What is the long-term trend for Adaptive Biotechnologies's total revenue?

Over 4 years (2021 to 2025), Adaptive Biotechnologies's total revenue has grown at a 15.7% compound annual growth rate (CAGR), from $154.34M to $276.98M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Adaptive Biotechnologies ADPT Total Revenue

Total Revenue at other companies

Guardant HealthGH

$301.67M+48.3%

Natera, Inc.NTRA

$696.64M+38.8%

RevvityRVTY

$711.12M+7.0%

VeracyteVCYT

$139.07M+21.5%

DanaherDHR

$5.95B+3.7%

Charles River LaboratoriesCRL

$995.83M+1.2%

Segments

By product

See full

Service$58.09M+48.1%

Regulatory Milestone Revenue$9M+100%

Service And Licensing Revenue$3.78M—

Collaboration Revenue$0-100%

By segment

See full

Mrd Business$67.09M+53.5%

Immune Medicine Business$3.78M-56.6%

Other financials

Income statement

See full

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's total revenue?: Adaptive Biotechnologies (ADPT) reported total revenue of $70.87M in Q1 2026.
How has Adaptive Biotechnologies's total revenue changed year-over-year?: Adaptive Biotechnologies's total revenue increased by 35.1% year-over-year, from $52.44M to $70.87M.
What is the long-term trend for Adaptive Biotechnologies's total revenue?: Over 4 years (2021 to 2025), Adaptive Biotechnologies's total revenue has grown at a 15.7% compound annual growth rate (CAGR), from $154.34M to $276.98M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.